Scott M. Apana
Researcher
Also affiliated: American Institute of Certified Public Accountants (2016); United States Food and Drug Administration (2016); Center for Drug Evaluation and Research (2016); University of Arkansas Medical Center (2011); Arkansas Cardiology (2009); Photon Imaging (United States) (2014); Arkansas Department of Agriculture (2009–2016)
Faculty Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Scott M. Apana's research focuses on investigating the neurochemical effects of central nervous system stimulants, particularly methylphenidate, in nonhuman primate models. His work has explored the long-term impacts of methylphenidate treatment and the consequences of its discontinuation. Apana utilizes Positron-Emission Tomography (PET) and Computed Tomography (CT) imaging techniques to assess these effects in the brain. He has collaborated with researchers from the National Center for Toxicological Research, including John Talpos, Merle G. Paule, and X. Zhang, on multiple publications. Apana's scholarship metrics include an h-index of 11, with 25 total publications and 486 total citations.
Metrics
- h-index: 11
- Publications: 25
- Citations: 488
Selected Publications
-
Discontinuation of methylphenidate after long-term exposure in nonhuman primates (2023)
-
MicroPET/CT assessment of neurochemical effects in the brain after long-term methylphenidate treatment in nonhuman primates (2021)
-
MicroPET/CT assessment of FDG uptake in brain after long-term methylphenidate treatment in nonhuman primates (2016)
-
In Vivo Monitoring of Sevoflurane-induced Adverse Effects in Neonatal Nonhuman Primates Using Small-animal Positron Emission Tomography (2016)
-
Abstract 4644: A novel strategy for targeted drug delivery to the tumor vasculature by radiation-induced receptor expression on endothelial cells (2012)
-
Radiation-induced galectin-1 by endothelial cells: a promising molecular target for preferential drug delivery to the tumor vasculature (2012)
-
MicroPET/CT Imaging of [ <sup>18</sup> F]-FEPPA in the Nonhuman Primate: A Potential Biomarker of Pathogenic Processes Associated with Anesthetic-Induced Neurotoxicity (2012)
-
Repression of Multiple Myeloma Growth and Preservation of Bone with Combined Radiotherapy and Anti-angiogenic Agent (2010)
Collaboration Network
Top Collaborators
- MicroPET/CT assessment of neurochemical effects in the brain after long-term methylphenidate treatment in nonhuman primates
- Discontinuation of methylphenidate after long-term exposure in nonhuman primates
- MicroPET/CT assessment of neurochemical effects in the brain after long-term methylphenidate treatment in nonhuman primates
- Discontinuation of methylphenidate after long-term exposure in nonhuman primates
- MicroPET/CT assessment of neurochemical effects in the brain after long-term methylphenidate treatment in nonhuman primates
- Discontinuation of methylphenidate after long-term exposure in nonhuman primates
- MicroPET/CT assessment of neurochemical effects in the brain after long-term methylphenidate treatment in nonhuman primates
- Discontinuation of methylphenidate after long-term exposure in nonhuman primates
- MicroPET/CT assessment of neurochemical effects in the brain after long-term methylphenidate treatment in nonhuman primates
- MicroPET/CT assessment of neurochemical effects in the brain after long-term methylphenidate treatment in nonhuman primates
- Discontinuation of methylphenidate after long-term exposure in nonhuman primates
Similar Researchers
Based on overlapping research topics